RE
Insider selling
Robert E. Gagnon sold $127K of Opus Genetics, Inc. (IRD) stock
Robert E. Gagnon, Chief Financial Officer of Opus Genetics, Inc. (IRD), sold 28,000 shares of IRD stock worth $127K, per an SEC Form 4 filed Sep 8, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 3, 2026, 5 days before it was made public.
IRD has moved +0.9% since the trade date, from $4.60 to $4.64 (Oct 12, 2026 close).
- Traded
- Sep 3, 2026
- Disclosed
- Sep 8, 2026
- Filing delay
- 5 days
- Price since
- +0.9%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More IRD insider and Congress trades
- SellIRD · Foundation Fighting Blindness Retinal Degeneration Fund$2.8MOct 2, 2026
- SellIRD · George Magrath$28KJul 27, 2026
- SellIRD · Robert E. Gagnon$23KJul 27, 2026
- SellIRD · Benjamin R Yerxa$22KJul 27, 2026
- SellIRD · Joseph K Schachle$14KJul 27, 2026
- SellIRD · Foundation Fighting Blindness Retinal Degeneration Fund$7.4MMay 20, 2026
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.